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Conclusion: DWA combines direct machine parameter 
optimization with noncoplanar geometry, allowing additional 
flexibility in dose delivery, while preserving dosimetrically 
robust delivery. 
 
Proffered Papers: RTT 5: Optimizing treatment planning 
and delivery in the pelvic region  
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Purpose or Objective: Radiotherapy treatment for cervical 
cancers typically involves external beam irradiation to the 
whole pelvis followed by an intra-uterine brachytherapy 
boost to the primary tumour site. The purpose of the current 
study was 1) to assess dose reduction to OARs using a VMAT 
treatment technique compared to a conformal four field 
brick and 2) whether VMAT using sequential or simultaneous 
integrated boost can provide coverage to the tumour and 
OARs similar to brachytherapy. 
 
Material and Methods: Ten patients previously treated for 
cervical cancer were identified (age range 30-78 years). Four 
plans were retrospectively produced for each patient (3D 
conformal four field brick, VMAT to the whole pelvis, VMAT 
boost, SIB) providing a phase one dose of 50.4Gy over 28 
fractions. The sequential boost dose varied between patients 
from 16.5Gy-27.5Gy over 3-5 fractions. An averaged boost 
dose of 31Gy over 32 fractions, corrected using biological 
equivalent dose calculations was used for all SIB plans. All 
data was corrected to EQD2.  
 
Figure1: Typical dose distribution for a VMAT with SIB plan. 
 
 
 
Results: Results demonstrated significantly improved dose 
homogeneity between the VMAT and four field phase one 
techniques (p<0.01) but failed to find significant dose 
reductions to the bladder and rectum. Dose to the bowel was 
reduced at all dose points (p<0.01). Comparing the VMAT and 
brachytherapy boost, significantly increased doses to OARs 
were identified in the VMAT boost (bladder p<0.05; rectum 
p<0.01; bowel p<0.01). Dose homogeneity was decreased 
using an SIB compared to sequential but OAR doses were also 
decreased (p<0.05).  
Table 1: Mean and standard deviation of OAR data contained 
within the SIB and VMAT phase one plus either boost or 
brachytherapy plan combinations. 
 
 
 
Conclusion: When treating cervical cancer, VMAT allowed 
significant improvement in dose homogeneity with overall 
reductions in doses to OARs. When comparing the feasibility 
of SIB or sequential EBRT boost instead of brachytherapy the 
SIB plan produced a better solution with respect to OAR 
doses. Whilst cervical surface doses with SIB to the high-risk 
CTV will not match brachytherapy a SIB may offer an 
alternative option for those patients who refuse/cannot 
access brachytherapy. 
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